Lanceo SRL
The score of Lanceo shows with a free account.
See the score- Summary? / 5
- Solvency
- Liquidity
- Interest coverage
- Profitability
- Leverage
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +29 % Total assets +26 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Lanceo's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 39,841 € | ||||
| Equity | 252,857 € | ||||
| Cash | 52,429 € | ||||
| EBITDA | 62,753 € | ||||
| Total assets | 291,955 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Aug 2026
- Year ended 31 Dec 2024filed on 29 Aug 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 21 Jul 2023
- Year ended 31 Dec 2021filed on 29 Aug 2022
Lanceo's financial analysis
- Solvency86.6%sector median: 56.3%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Lanceo
Lanceo's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0835.404.283
- VAT number
- BE0835404283
- Peppol
- Registered · 0208:0835404283 · as of 24 Oct 2026
- Legal form
- SRL
- Incorporated
- 08 Apr 2011
- Registered office
- 2290 Vorselaar
- Latest accounts
- 2025 · filed on 30 Aug 2026
- Activity
- Manufacture of basic pharmaceutical products (NACE 21100)
Lanceo (SRL) has been based in Vorselaar since 2011, active in: manufacture of basic pharmaceutical products. For 2025, it reports a net profit of 39,841 € and equity of 252,857 €; its revenue is not published. Its solvency stands at 86.6%, above the median of its sector (56.3%).
Companies similar to Lanceo
Companies in the same business, of comparable size and area, outside its group.
- International Mushroom Consulting Jans Market research and public opinion polling Kinrooi · balance sheet 355,308 €
- Hansma International Manufacture of basic pharmaceutical products Bonheiden · balance sheet 75,376 €
- Asclepia MedChem Solutions Manufacture of basic pharmaceutical products Destelbergen · balance sheet 360,741 €
- Pledge Therapeutics Manufacture of basic pharmaceutical products Leuven · balance sheet 229,854 €
- DS Consult Market research and public opinion polling Bilzen-Hoeselt · balance sheet 499,103 €
- ASM Services & Consulting Market research and public opinion polling Hasselt · balance sheet 590,643 €
- Medipharm Worldwide Group Manufacture of basic pharmaceutical products Tienen · balance sheet 331,081 €
- Exeltis Belgium Wholesale of pharmaceutical and medical goods Brussels · balance sheet 621,109 €
Frequently asked questions about Lanceo
What is the revenue of Lanceo?
Lanceo files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Lanceo?
In Belgium, the VAT number is the company number prefixed with BE: BE0835404283 for Lanceo, if the company is VAT-registered. Its company number (CBE) is 0835.404.283.
Where is the registered office of Lanceo?
According to the CBE register, the registered office of Lanceo is in 2290 Vorselaar.
What is the equity of Lanceo?
At the close of the 2025 financial year, the equity of Lanceo amounts to 252,857 €, a solvency of 86.6% of total assets.
Who manages Lanceo?
The register lists 2 active mandates at Lanceo. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Lanceo
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →